LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that it has created a direct sales organization and initiated the commercial launch of the iStent inject® Trabecular Micro-Bypass Stent in Canada. The iStent inject system is preloaded with two micro-scale stents that the surgeon p
TOKYO–(BUSINESS WIRE)–PENTAX Medical, a division of HOYA Group, has announced the appointment of Gerald W. Bottero to the position of Global President of PENTAX Medical as of February 1st, 2016.
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — HOYAグループPENTAX Medical事業部はこのたび、2016年2月1日付でジェラルド・W. ボッテロが医療用内視鏡の製造・販売を行うPENTAX Medical事業部長に就任したことを発表します。 HOYA株式会社 代表執行役最高経営責任者 (CEO)である鈴木 洋は、ボッテロの事業部長就任にあたり「ボッテロをPENTAX Medical事業のグローバルリーダーとして迎えることができ、大変うれしく思います。ＨＯＹＡグループでの様々な要職を経て彼が得た豊富な見識と経験、リーダーシップは、PENTAX Medicalのグローバルな成長への大きな推進力となると確信しています。」と述べています。 ボッテロは1989年にHOYA株式会社に入社後、様々な事業に携わってきました。直近では、2005年まではHOYA Conbio（皮膚科/歯科用レーザー治療機器）、Decibel Instruments（補聴器）、Lifespex, Inc.（子宮頸がんの早期発見ソリューション）で取締役を、そして2005年4月から2014年
(MedPage Today) — Measure would require state to bargain harder with drug companies
(MedPage Today) — Breast cancer drug gains approval for liposarcoma
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its U.S. joint venture with G-treeBNT, ReGenTree LLC, has completed enrollment of its Phase 2b/3 dr…
Researchers from Massachusetts Eye and Ear/Harvard Medical School have described, for the first time, the adult brain’s ability to compensate for a near-complete loss of auditory nerve fibers that link the ear to the brain. The findings, published in t…
LONDON–(BUSINESS WIRE)–Bloomberg has unveiled its inaugural Bloomberg Business Innovators list, naming MyOptique Group as one of the breakthrough businesses disrupting the way people live, work and think in the UK.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/9fzv2r/macular_edema) has announced the addition of the “Macular Edema – Pipeline Review, H2 2015” report to their offering. This report provides comprehensive in…
BROOKLYN, N.Y.–(BUSINESS WIRE)–Former NYC OEM Commissioner Joseph F. Bruno named President/CEO of Helen Keller Services (HKS), a national organization founded in 1893. Bruno has been an active board trustee for over 16 years.
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/dnb8jz/retinal) has announced the addition of the “Retinal Degeneration-Pipeline Insights, 2016” report to their offering. Retinal Degeneration-Pipeline Insights,…
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/w37p44/retinal_vein) has announced the addition of the “Retinal Vein Occlusion-Pipeline Insights, 2016” report to their offering. Retinal Vein Occlusion-Pipeline …
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/xjcxm8/retinal) has announced the addition of the “Retinal Degeneration – Pipeline Review, H2 2015” report to their offering. This report provides comprehensive i…
TOKYO–(BUSINESS WIRE)–Hoya Corporation (TOKYO: 7741) today announced financial results for the third quarter ended December 31, 2015. During the quarter, the Group sales totaled 127,645 million yen, decreasing by 0.4% from the same period last year. …
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4t3ppk/cataract) has announced the addition of the “Cataract – Pipeline Review, H2 2015” report to their offering. This report provides comprehensive information …
In patients with persistent diabetic macular edema (DME), there may be long-term benefits to be gained from continuing with anti-vascular endothelial growth factor (anti-VEGF) therapy, according to a post hoc analysis of a Diabetic Retinopathy Clinical…
(MedPage Today) — Closer than you think, says Davis Liu, MD
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/4stpf7/bacterial) has announced the addition of the “Bacterial Conjunctivitis-Pipeline Insights, 2016” report to their offering. Bacterial Conjunctivitis-Pipeline…
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/zw29tf/rhinoconjunctivit) has announced the addition of the “Rhino-Conjunctivitis-Pipeline Insights, 2016” report to their offering. Rhino-Conjunctivitis-Pipeline…
LEXINGTON, Mass.–(BUSINESS WIRE)–Cadmus Rich, MD, Vice President, Medical Affairs and Clinical Development of Inotek, will present at Glaucoma 360: New Horizons Forum on Friday, January 29, 2016 at the Palace Hotel in San Francisco.